# Accelerating Medicines Partnership in RA and Lupus: Network Sites (UH2/UH3)

> **NIH NIH UH2** · JOHNS HOPKINS UNIVERSITY · 2020 · $109,611

## Abstract

   
DESCRIPTION (provided by applicant): The Hopkins Lupus Cohort is a longitudinal study of over 2,300 SLE patients followed every 3 months by protocol. Through our collaborative effort and partnership with different institutions and by supplying patient samples, we will help answers many unanswered questions. Identifying the biological pathways of renal progression could result in targeted therapeutics. Our partnership would also help in identifying genes or gene signatures associated with SLE disease activity or related organ damage could elucidate the pathways by which pathology occurs and result in targeted treatments offered to the correct subset of patients. Also, by Identifying pathways that lead to flares in disease can be used to develop therapeutics to prevent flares.

## Key facts

- **NIH application ID:** 10200982
- **Project number:** 3UH2AR067679-05S1
- **Recipient organization:** JOHNS HOPKINS UNIVERSITY
- **Principal Investigator:** MICHELLE A PETRI
- **Activity code:** UH2 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $109,611
- **Award type:** 3
- **Project period:** 2014-09-24 → 2022-05-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10200982

## Citation

> US National Institutes of Health, RePORTER application 10200982, Accelerating Medicines Partnership in RA and Lupus: Network Sites (UH2/UH3) (3UH2AR067679-05S1). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10200982. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*